Quoin Pharmaceuticals, Ltd. (QNRX) › Cash & EquivalentsQuoin Pharmaceuticals, Ltd. (QNRX) — Cash & EquivalentsAnnual figures by period end, from SEC filings.2020-12-31: $323.8K2021-12-31: $7.48M2022-12-31: $2.86M2023-12-31: $2.40M2024-12-31: $3.62M2025-12-31: $3.82M$3.82M2020-12-31Cash & Equivalents (USD)2025-12-31Period endedCash & EquivalentsChange YoYSource filing2025-12-31$3.82M+5.4%2026-03-26Balance as of period end2024-12-31$3.62M+50.9%2026-03-26Balance as of period end2023-12-31$2.40M-16.1%2025-03-13Balance as of period end2022-12-31$2.86M-61.8%2024-03-14Balance as of period end2021-12-31$7.48M+2210.7%2023-03-15Balance as of period end2020-12-31$323.8K—2022-04-14Balance as of period endOther metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per ShareWeighted Average Diluted SharesEPS (Basic)